Aptus Pharma Board of Directors

Get the latest insights into the leadership at Aptus Pharma. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Tejash Maheshchandra HathiManaging Director
Chetan Shantilal LalsetaNon Executive Director
Jyotiben Hasmukhbhai ChandaranaNon Executive Director
Riddhish Natwarlal TannaNon Executive Director
Vikas Rambhai JobanputraNon Executive Independent Director
Sejal Harit PalanNon Executive Independent Director
Mohini Hardikbhai GandhiCompany Secretary & Compliance Officer

Aptus Pharma Share price

APPL

360.5

4.50 (-1.23%)
Last updated on 23 Apr, 2026 | 15:15 IST
Today's High

360.50

Today's Low

360.50

52 Week Low

80.80

52 Week High

387.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aptus Pharma FAQs

The board at Aptus Pharma consists of experienced professionals, including Tejash Maheshchandra Hathi, Chetan Shantilal Lalseta, and others, overseeing the company’s strategic and corporate governance.

Directors at Aptus Pharma are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Tejash Maheshchandra Hathi is the current chairman at Aptus Pharma.

Executive directors at Aptus Pharma are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Aptus Pharma adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Aptus Pharma, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost